AUTO-UPDATED

You Can’t See Anything About Billy Evans’s New Start-up

Billy Evans, the partner of Elizabeth Holmes, has launched a secretive blood-testing startup called Haemanthus that utilizes laser technology and AI to pursue radical health diagnostics.

Key Points

  • Haemanthus is developing a diagnostic device that uses Raman spectroscopy to analyze blood, saliva, and urine samples for human health optimization.
  • The company is currently bypassing FDA oversight by conducting initial testing on animals under Department of Agriculture regulations.
  • Evans has raised approximately $18.15 million in funding, including $3.15 million from friends and family and $15 million from institutional investors.
  • The startup aims to shrink its diagnostic technology into a wearable device, projecting a three-year development timeline and a $70 million budget.
  • Despite public speculation linking the venture to Theranos, Haemanthus maintains that Elizabeth Holmes has no formal involvement in the company.

Why it Matters

The launch of Haemanthus invites intense scrutiny due to the founder's personal connection to Elizabeth Holmes and the striking similarities between his startup's goals and the failed Theranos model. Investors and regulators remain cautious, as the company attempts to navigate the high-stakes diagnostics market while managing the reputational baggage associated with the infamous blood-testing fraud.
New York Magazine Published by Matt Stieb
Read original